M&A activity was also up in 2005 with 205 deals completed compared to the 159 deals in 2004. Large pharmaceutical and biotechnology companies acquired products, expertise, and interestingly vaccine development and production infrastructure.(00:56:09) The largest deals focused on marketed or late st...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
